News
ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced data from preclinical studies of three exatecan-based antibody drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback